Trp53bp1
M. musculus
transformation related protein 53 binding protein 1
What the model saw
Gene: Trp53bp1 Organism: Mus musculus Known functions: transformation related protein 53 binding protein 1. TP53-binding protein 1. RNA polymerase II-specific DNA-binding transcription factor binding. histone H4K20me methyltransferase activity. histone H4K20me2 reader activity. histone binding. histone reader activity. p53 binding. protein binding. transcription coactivator activity. transcription coregulator activity. ubiquitin-modified histone reader activity.
View unredacted entry
transformation related protein 53 binding protein 1. TP53-binding protein 1. RNA polymerase II-specific DNA-binding transcription factor binding. histone H4K20me methyltransferase activity. histone H4K20me2 reader activity. histone binding. histone reader activity. p53 binding. protein binding. transcription coactivator activity. transcription coregulator activity. ubiquitin-modified histone reader activity.
Solver output
53BP1 (TP53-binding protein 1) is a central mediator of the DNA damage response (DDR), functioning as a histone reader that recognizes H4K20me2 (dimethylated histone H4 lysine 20) and ubiquitin-modified histones at DNA double-strand break (DSB) sites. By reading these histone marks, 53BP1 is recruited to DSBs and promotes non-homologous end joining (NHEJ) while suppressing homologous recombination, thereby facilitating efficient repair of DSBs and maintaining genomic integrity. Its role as a p53 co-activator further links it to tumor suppression and the cellular response to genotoxic stress. Loss of 53BP1 leads to impaired DSB repair, increased genomic instability, and accelerated aging phenotypes in mice, consistent with a pro-longevity function. The histone H4K20me methyltransferase activity annotation also connects 53BP1 to chromatin compaction and epigenetic regulation of the DDR. Together, these functions place 53BP1 squarely in the genomic stability maintenance axis, where its normal activity opposes the accumulation of DNA damage that drives aging.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted "pro_longevity" with 0.75 confidence, but the ground truth is "anti_longevity." The model's reasoning that loss of 53BP1 leads to "accelerated aging phenotypes" is incorrect - in fact, 53BP1 knockout mice show extended lifespan or reduced aging-related pathologies in some contexts, or more relevantly, 53BP1 promotes NHEJ over HR which can be detrimental in certain contexts. The GenAge classification of anti_longevity suggests that 53BP1's normal activity actually shortens lifespan (i.e., its loss extends lifespan or its presence promotes aging). The model's mechanistic reasoning is also flawed - it assumes that because 53BP1 promotes DNA repair, it must be pro-longevity, but this oversimplifies the biology. 53BP1's role in promoting NHEJ (an error-prone repair pathway) over HR could actually contribute to genomic instability and aging rather than preventing it. The model was confidently wrong in both the direction of effect and the mechanistic interpretation.
Raw API responses
solver
{
"reasoning": "53BP1 (TP53-binding protein 1) is a central mediator of the DNA damage response (DDR), functioning as a histone reader that recognizes H4K20me2 (dimethylated histone H4 lysine 20) and ubiquitin-modified histones at DNA double-strand break (DSB) sites. By reading these histone marks, 53BP1 is recruited to DSBs and promotes non-homologous end joining (NHEJ) while suppressing homologous recombination, thereby facilitating efficient repair of DSBs and maintaining genomic integrity. Its role as a p53 co-activator further links it to tumor suppression and the cellular response to genotoxic stress. Loss of 53BP1 leads to impaired DSB repair, increased genomic instability, and accelerated aging phenotypes in mice, consistent with a pro-longevity function. The histone H4K20me methyltransferase activity annotation also connects 53BP1 to chromatin compaction and epigenetic regulation of the DDR. Together, these functions place 53BP1 squarely in the genomic stability maintenance axis, where its normal activity opposes the accumulation of DNA damage that drives aging.",
"confidence": 0.75,
"key_pathways": [
"DNA double-strand break repair via NHEJ (H4K20me2 reading at DSB foci)",
"p53-mediated DNA damage checkpoint signaling",
"Ubiquitin-histone mark reading at DNA damage sites"
],
"mechanism_class": "genomic_instability",
"longevity_influence": "pro_longevity"
}advisor
{
"notes": "The model predicted \"pro_longevity\" with 0.75 confidence, but the ground truth is \"anti_longevity.\" The model's reasoning that loss of 53BP1 leads to \"accelerated aging phenotypes\" is incorrect - in fact, 53BP1 knockout mice show extended lifespan or reduced aging-related pathologies in some contexts, or more relevantly, 53BP1 promotes NHEJ over HR which can be detrimental in certain contexts. The GenAge classification of anti_longevity suggests that 53BP1's normal activity actually shortens lifespan (i.e., its loss extends lifespan or its presence promotes aging). The model's mechanistic reasoning is also flawed - it assumes that because 53BP1 promotes DNA repair, it must be pro-longevity, but this oversimplifies the biology. 53BP1's role in promoting NHEJ (an error-prone repair pathway) over HR could actually contribute to genomic instability and aging rather than preventing it. The model was confidently wrong in both the direction of effect and the mechanistic interpretation.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}